Loading...
Loading...
Sub-Potent Drug: Subpotent assay results during stability testing.
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
Sub-Potent Drug: Subpotent assay results during stability testing.